TD Private Client Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.35M Sell
18,033
-4,826
-21% -$1.72M 0.13% 108
2025
Q4
$7.48M Sell
22,859
-3,426
-13% -$1.09M 0.16% 88
2025
Q3
$7.42M Buy
26,285
+677
+3% +$196K 0.17% 88
2025
Q2
$7.15M Buy
25,608
+1,495
+6% +$424K 0.18% 84
2025
Q1
$7.51M Buy
24,113
+1,475
+7% +$436K 0.21% 76
2024
Q4
$5.9M Buy
22,638
+996
+5% +$296K 0.17% 90
2024
Q3
$6.97M Sell
21,642
-2,367
-10% -$774K 0.2% 80
2024
Q2
$7.5M Buy
24,009
+2,952
+14% +$867K 0.24% 69
2024
Q1
$5.99M Sell
21,057
-2,194
-9% -$642K 0.2% 82
2023
Q4
$6.7M Sell
23,251
-9,519
-29% -$2.59M 0.24% 67
2023
Q3
$8.82M Sell
32,770
-998
-3% -$249K 0.38% 44
2023
Q2
$7.5M Buy
33,768
+7,492
+29% +$1.74M 0.32% 58
2023
Q1
$6.35M Buy
26,276
+6,202
+31% +$1.52M 0.29% 74
2022
Q4
$5.28M Sell
20,074
-9,420
-32% -$2.53M 0.25% 92
2022
Q3
$6.65M Buy
29,494
+4,488
+18% +$1.09M 0.34% 54
2022
Q2
$6.09M Sell
25,006
-255
-1% -$62.5K 0.3% 71
2022
Q1
$6.11M Buy
25,261
+8,171
+48% +$1.88M 0.26% 86
2021
Q4
$3.84M Buy
17,090
+2,244
+15% +$474K 0.16% 148
2021
Q3
$3.16M Buy
14,846
+4,312
+41% +$992K 0.14% 165
2021
Q2
$2.57M Sell
10,534
-1,900
-15% -$467K 0.11% 193
2021
Q1
$3.09M Buy
12,434
+159
+1% +$37.9K 0.14% 161
2020
Q4
$2.82M Buy
12,275
+1,178
+11% +$272K 0.14% 155
2020
Q3
$2.82M Sell
11,097
-919
-8% -$228K 0.16% 139
2020
Q2
$2.83M Buy
12,016
+1,253
+12% +$286K 0.17% 139
2020
Q1
$2.18M Sell
10,763
-1,924
-15% -$420K 0.16% 137
2019
Q4
$3.06M Buy
+12,687
New +$2.8M 0.18% 132

Other funds holding AMGN

TD Private Client Wealth's AMGN Position: Q1 2026 in Review

TD Private Client Wealth reduced its Amgen (AMGN) stake by 21% in Q1 2026, selling an estimated $1.72M and leaving 18,033 shares worth $6.35M. The position accounts for 0.13% of the portfolio, ranked #108.

TD Private Client Wealth first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.82M in Q3 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • TD Private Client Wealth held 18,033 shares of Amgen worth $6.35M as of Q1 2026.
  • TD Private Client Wealth sold 4,826 Amgen shares in Q1 2026, an estimated $1.72M.
  • Amgen made up 0.13% of TD Private Client Wealth's portfolio in Q1 2026, its #108 holding.
  • TD Private Client Wealth first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Amgen position peaked at $8.82M in Q3 2023.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.